ScopeSys is commercializing a new single-molecule imaging technology called Convex Lens-induced Confinement (CLiC). This technique offers unprecedented capabilities for measuring individual molecular interactions in their native, solvated environment over long times and with high throughput. Our assays are focused on two areas related to the development of new biological therapeutics: single-molecule measurement of oligonucleotide binding kinetics to RNA and DNA targets, and nanoparticle analytics for drug delivery applications. Our technology offers the ability to track multiple molecules to sequence the mechanism of complex reactions, as well as the ability to measure both size and loading of individual nanoparticles to characterize drug uptake and release over time.